Liver News

Practical strategies for pruritus management in the obeticholic acid-treated patient with PBC: proceedings from the 2018 expert panel.

Practical strategies for pruritus management in the obeticholic acid-treated patient with PBC: proceedings from the 2018 expert panel.

April 8, 2019 | By | Publications

This article provides expert guidance on the management of pruritus symptoms in patients receiving obeticholic acid (OCA) as treatment for primary biliary cholangitis (PBC).

Alcoholic Liver Disease: High Risk or Low Risk for Developing Hepatocellular Carcinoma?

Alcoholic Liver Disease: High Risk or Low Risk for Developing Hepatocellular Carcinoma?

April 8, 2019 | By | Publications

In this review we critically assess the literature to evaluate the level of risk posed by alcohol as both a primary etiology of hepatocellular carcinoma (HCC) and

Treatment of Hepatitis C A Systematic Review

Treatment of Hepatitis C A Systematic Review

April 8, 2019 | By | Publications

Abstract: Hepatitis C virus (HCV) infects more than 185 million individuals worldwide. Twenty percent of patients chronically infected with HCV progress to cirrhosis. New, simpler therapeutics using direct-acting antivirals that target various stages of the HCV life cycle are in development to eradicate HCV without concomitant interferon.

Re-treatment of Chronic HCV Genotype 1 Infection After Relapse | Annals of Internal Medicine | American College of Physicians

Re-treatment of Chronic HCV Genotype 1 Infection After Relapse | Annals of Internal Medicine | American College of Physicians

April 8, 2019 | By | Publications

The interferon (IFN)–free regimen of sofosbuvir and ribavirin for 24 weeks was recently approved to treat chronic hepatitis C virus (HCV) genotype 1 (GT-1) infection for patients ineligible for IFN. However, sofosbuvir plus ribavirin therapy is associated with relapse in 15% to 30% of patients with HCV GT-1.

Liver Disease and Advances in Screening Technology

Liver Disease and Advances in Screening Technology

April 5, 2019 | By | Presentations, Video Lectures

Our very own Ann Moore joins Wayne Eskridge to discuss advances in liver disease screening technology.

Liver Disease Diet from Liver Foundation

Liver Disease Diet from Liver Foundation

March 22, 2019 | By | Publications

If you’re a liver patient, your diet is adjusted to meet your individual needs. Talk to your doctor about what’s best for you. Still, here are some general food tips for a healthy or healthier liver:

The GP Show (Podcast)

The GP Show (Podcast)

March 22, 2019 | By | Podcasts

Join GP and Medical Educator Dr Sam Manger MBBS BSc FRACGP FASLM covering a variety of topics with case studies, guideline reviews, guest interviews and more for medical doctors and allied…

Anita Kohli, MD discusses her recent article in Annals of Internal Medicine

Anita Kohli, MD discusses her recent article in Annals of Internal Medicine

March 22, 2019 | By | Presentations, Video Lectures

Watch author, Anita Kohli, MD, discuss “Re-treatment of Chronic Hepatitis C Virus Genotype 1 Infection After Relapse. An Open-Label Pilot Study.”

Chronic Liver Disease Foundation Publication

Chronic Liver Disease Foundation Publication

March 22, 2019 | By | Publications

Abstract: Hepatitis C virus (HCV) infection is the leading reason for liver transplantation and a common cause of hepatocellular carcinoma, the most rapidly increasing cause of cancer-related deaths…

Liver Cancer Consortium Webinar

Liver Cancer Consortium Webinar

March 22, 2019 | By | Video Lectures

In partnership with the American Liver Foundation, our very own Dr. Richard Manch a consortium on liver cancer.